Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > Reliance Mutual Fund > Reliance Pharma Fund (Bonus)

Reliance Pharma Fund (Bonus)

PLAN: Regular OPTIONS: Bonus
144.734 1.4 (0.98%)

NAV as on 19 Jan, 2018

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL (for quarter ended Sep 2017) since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on 19 Jan, 2018)

Period Returns (%) Rank #
1 mth 2.7 -
3 mth 8.7 -
6 mth 6.3 -
1 year 8.8 -
2 year 2.3 -
3 year 4.1 -
5 year 16.2 -

# Moneycontrol Rank within 8 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2017 0.7 -5.9 -0.1 12.1 7.4
2016 -12.3 2.2 6.4 -8.4 -10.5
2015 9.5 -4.4 14.2 -3.4 19.3
2014 3.5 10.8 25.0 3.4 48.5
2013 -6.3 5.4 3.2 14.6 20.5

View where it stands within its peers

* Returns over 1 year are Annualised

* Calculation Remark - Dividends are reinvested at the rate of return

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns 2.7 8.7 6.3 8.8 2.3 4.1 16.2
Category avg 3.1 5.7 3.6 3.2 -0.2 2.3 11.8
Difference of Fund returns and Category returns -0.4 3.0 2.7 5.6 2.5 1.8 4.4
Best of category 4.1 9.0 6.8 9.8 3.3 5.0 18.4
Worst of category 1.9 4.2 0.2 1.2 -3.5 1.8 14.2
Benchmark returns # 4.8 5.2 -1.0 0.2 -2.3 -- --
Difference of Fund returns and Benchmark returns -2.1 3.5 7.3 8.6 4.6 4.1 16.2
# Benchmark Index: S&P BSE HEALTHCARE

Investment Info

Investment Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Scheme details

Fund Type Open-Ended
Investment Plan Bonus
Launch date May 26, 2004
Benchmark S&P BSE HEALTHCARE
Asset Size (Rs cr) 4.68 (Dec-31-2017)
Minimum Investment Rs.5000
Last Dividend N.A. View Dividend History
Bonus N.A.
Fund Manager Sailesh Rajbhan
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 1.00%
Load Comments Exit load - 1% if redeemed/switched out on or before completion of 1 yrs from the date of allotment.

Contact Details

Regd. Office One India Bulls Centre - Tower One, 11th & 12th floor, Jupiter Mills Compound, Elphinstone Road, Mumbai , 400013
Tel. No. 022-30994600
Fax No. 91 22 30414899
Email customer_care@reliancemutual.com
Website http://www.reliancemutual.com/

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
1,536.22 8.7 6.3 8.8 4.1 16.2
SBI Pharma Fund (G) Not Ranked
860.04 4.2 1.0 -- 2.9 17.3
UTI Pharma & Health (G) Not Ranked
329.03 6.9 3.5 4.4 1.8 14.2
Reliance Pharma Fund - Direct (G) Not Ranked
215.62 9.0 6.8 9.8 5.0 17.2
SBI Pharma Fund - Direct (G) Not Ranked
214.61 4.6 1.7 1.2 4.2 18.4
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Dec 29, 17)

Equity Sector Value
(Rs cr)
Asset %
Divis Labs Pharmaceuticals 173.81 11.28
Abbott India Pharmaceuticals 144.38 9.37
Biocon Pharmaceuticals 144.23 9.36
Cipla Pharmaceuticals 130.05 8.44
Sun Pharma Pharmaceuticals 128.82 8.36
Dr Reddys Labs Pharmaceuticals 128.05 8.31
Sanofi India Pharmaceuticals 118.19 7.67
Aurobindo Pharm Pharmaceuticals 108.79 7.06
Thyrocare Techn Services 101.55 6.59
Torrent Pharma Pharmaceuticals 72.27 4.69

Full Portfolio

Sector Allocation (Dec 29, 17)

Sector %

1-Year

HighLow

Pharmaceuticals 82.81 82.83 82.83
Services 12.85 11.98 11.98
Manufacturing 1.82 3.94 3.94
Miscellaneous 0.56 0.00 0.00

View All Sectors

Asset Allocation (%)(Dec 29, 17)

Equity 98.04
Others 1.10
Debt 0.00
Mutual Funds N.A
Money Market 1.50
Cash / Call -0.64

View All

Concentration

Holdings (%)
Top 5 46.81
Top 10 81.13
Sector (%)
Top 3 97.48

News & Videos

News

Messages & Community

Sections
Follow us on
Available On